Journal of Comparative Physiology B

, Volume 155, Issue 3, pp 367–371 | Cite as

Species differences in the distribution of adrenal free and sulfoconjugated catecholamines

  • Karoly Racz
  • Otto Kuchel
  • Nguyen T. Buu


We determined free and sulfoconjugated catecholamines (CA) in adrenals of several species by reverse-phase high performance liquid chromatography (HPLC) with electrochemical detection. The two main adrenal CA, free epinephrine (E) and norepinephrine (NE) from eight species (guinea-pig, rat, dog, mice, bovine, cat, green-monkey and human) were considerably different both in the total amount as well as their relative proportions. Free dopamine (DA) content also differed from species to species but this CA was present in a relatively constant proportion, representing about 1% of the total free CA. Phenolsulfotransferase (PST) activity was present in all of the adrenals. Sulfoconjugated CA, however, were only selectively present: E and NE sulfate were entirely absent but in most of these species DA sulfate was detected in a proportion corresponding to 1–10% of the total (free + sulfoconjugated) DA. The adrenal DA sulfate concentrations did not parallel the adrenal PST activity, indicating that this enzyme can not be considered to be an index of the CA sulfates present in this organ.


Sulfate Dopamine Liquid Chromatography High Performance Liquid Chromatography Norepinephrine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.











high performance liquid chromatography






Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Almgren O, Carlsson A, Snider S (1979) Tissue dopamine levels as an indicator of tyrosine hydroxylase activity. In: Imbs JL, Schwartz J (eds) Peripheral dopaminergic receptors. Pergamon Press, New York, pp 29–40Google Scholar
  2. Anton AH, Sayre DF (1962) A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138:360–375Google Scholar
  3. Brundin T (1965) Catecholamines in adrenals from fetal rabbits. Acta Physiol Scand 63:509–510Google Scholar
  4. Buu NT, Kuchel O (1979) Dopamine-4-O-sulfate: A possible precursor of free norepinephrine. Can J Biochem 57:1159–1162Google Scholar
  5. Buu NT, Duhaime J, Savard C, Truong L, Kuchel O (1981) Presence of conjugated catecholomines in rat brain: A new method of analysis of catecholamine sulfates. J Neurochem 36:769–772Google Scholar
  6. Ciaranello D, Black IB (1971) Kinetics of the glucocorticoid-mediated induction of phenylethanolamine N-methyl transferase in the hypophysectomized rat. Biochem Pharmacol 20:3529–3532Google Scholar
  7. Coupland RE (1981) Catecholamine secreting tissues. Normal and pathological states. In: Potherby K, Pal SB (eds) Hormones in normal and abnormal tissues. Walter de Gruyter, Berlin, pp 589–663Google Scholar
  8. Elchisak MA, Carlson JH (1982) Assay of free and conjugated catecholamines by high-performance liquid chromatography with electrochemical detection. J Chromatogr 233:79–88Google Scholar
  9. Eranko O, Raisanen L (1956) Adrenaline and noradrenaline in the adrenal medulla during postnatal development of the rat. Endocrinology 60:753–760Google Scholar
  10. Euler US von, Franksson C, Hellstrom J (1953) Adrenaline and noradrenaline content of surgically removed human suprarenal glands. Acta Physiol Scand 31:6–8Google Scholar
  11. Foldes A, Meek JL (1973) Rat brain phenolsulphotransferase —Partial purification and some properties. Biochem Biophys Acta 327:365–374Google Scholar
  12. Holton P (1951) High concentration of noradrenaline in calves' suprarenals. Nature 167:858–859Google Scholar
  13. Jenner WN, Rose FA (1973) Studies on the sulphation of 3,4-dihydroxyphenylethylamine (dopamine) and related compounds by rat tissues. Biochem J 135:109–114Google Scholar
  14. Kuchel O, Buu NT, Wang PC (1982) Stress, catecholamines and hypertension: Respective roles of free and conjugated catecholamines. Stress 3:22–31Google Scholar
  15. Kuchel O, Buu NT, Roy P, Hamet P, Larochelle P, Genest J (1984) Regional sources of free and sulfated catecholamines in hypertension. Hypertension 6 (Suppl I) I-51–I-55Google Scholar
  16. Maemura S, Niwa M, Ozaki M (1982) Characteristic alterations in adrenal catecholamine contents in SHR, SHRSP, and WKY during development of hypertension and stroke. Jpn Heart J 23:593–602Google Scholar
  17. McGoodall C (1951) Studies of adrenaline and noradrenaline in mammalian heart and suprarenals. Acta Physiol Scand 24:43–51Google Scholar
  18. Rastgeldi S (1951) Adrenaline and noradrenaline in the whale suprarenal glands. Acta Physiol Scand 23:44–46Google Scholar
  19. Snider SR (1974) Increase in adrenal dopamine following 6-hydroxydopamine. J Pharm Pharmacol 26:647–649Google Scholar
  20. Vandermeulen R, Cession-Fossion A, Peeters G (1968) Présence de dopamine dans les surrénales de la chèvre (Capra hircus). Arch Int Physiol Biochim 76:916–919Google Scholar
  21. Vandermeulen R, Cession-Fossion A, Lecomte J, Orban F, Lejeune G (1969) Présence de dopamine dans les surrénales humaines. Rev Fr Etudes Clin Biol 14:283–284Google Scholar
  22. West GB (1955) The comparative pharmacology of the adrenal medulla. Q Rev Biol 30:116–137Google Scholar
  23. Wurtman RJ, Axelrod J (1966) Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. J Biol Chem 241:2301–2305Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Karoly Racz
    • 1
  • Otto Kuchel
    • 1
  • Nguyen T. Buu
    • 1
  1. 1.Laboratory of the Autonomic Nervous SystemClinical Research Institute of MontrealMontrealCanada

Personalised recommendations